Completed Research Studies

2. Title: Safety and Pharmacokinetics of Riluzole in Patients with Acute Traumatic Spinal Cord Injury

Purpose: The primary aim of this study is to develop acute care safety and pharmacokinetic profiles of Riluzole in patients who have sustained a traumatic spinal cord injury. Secondary objectives are to conduct exploratory analyses of functional outcomes for purposes of planning a subsequent Phase II b - Phase III randomized study of the efficiency of Riluzole for the treatment of acute spinal cord injury.

Principal Investigator: James S. Harrop, MD
Co-Investigator(s): Ralph J. Marino, MD

Study Dates: July 1, 2010 - June 30, 2011

Status: Study Completed

Contact Us | Website Survey | Search